There was no evidence identified concerning the clinical effectiveness of glyburide when compared to gliclazide or glimepiride for elderly patients with type 2 diabetes. The evidence available concerning the safety of glyburide, gliclazide or glimepiride is limited and inconclusive. In one study there is some suggestion that glyburide may be associated with a greater risk of all-cause mortality compared to gliclazide.